| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-05-11 18:26:11 UTC |
|---|
| Updated at | 2022-05-11 18:26:11 UTC |
|---|
| NP-MRD ID | NP0090928 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | LysoPC(18:0) |
|---|
| Description | LysoPC(18:0/0:0), Also known as LPC(18:0/0:0) Or 18:0 Lyso-PC, belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, lysopc(18:0/0:0) Is considered to be a glycerophosphocholine lipid molecule. LysoPC(18:0/0:0) Is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. LysoPC(18:0/0:0) Exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, LysoPC(18:0/0:0) Has been detected, but not quantified in, several different foods, such as cow milks, cow milks, cow milks, cow milks, and milk (cow). This could make lysopc(18:0/0:0) A potential biomarker for the consumption of these foods. LysoPC(18:0) is found in Ailuropoda melanoleuca, Aphis gossypii, Homo sapiens and Trypanosoma brucei. LysoPC(18:0) was first documented in 2010 (PMID: 20060459). A lysophosphatidylcholine 18:0 In which the acyl substituent is located at position 1 and is specified as stearoyl (PMID: 22952663) (PMID: 23729004). |
|---|
| Structure | [H][C@@](O)(COC(=O)CCCCCCCCCCCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C InChI=1S/C26H54NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h25,28H,5-24H2,1-4H3/t25-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (2R)-2-Hydroxy-3-(stearoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate | ChEBI | | 1-O-Stearoyl-sn-glycero-3-phosphocholine | ChEBI | | 1-Octadecanoyl-sn-glycero-3-phosphocholine | ChEBI | | 1-Stearoyl-glycero-3-phosphocholine | ChEBI | | 1-Stearoylglycerophosphocholine (18:0) | ChEBI | | 1-Stearoylglycerophosphocholine(18:0) | ChEBI | | 18:0 LYSO-PC | ChEBI | | GPCho 18:0/0:0 | ChEBI | | GPCho(18:0/0:0) | ChEBI | | LPC 18:0/0:0 | ChEBI | | LPC(18:0) | ChEBI | | LPC(18:0/0:0) | ChEBI | | LysoPC 18:0/0:0 | ChEBI | | LysoPC(18:0) | ChEBI | | Lysophosphatidylcholine (18:0/0:0) | ChEBI | | Lysophosphatidylcholine(18:0) | ChEBI | | Lysophosphatidylcholine(18:0/0:0) | ChEBI | | PC 18:0/0:0 | ChEBI | | PC(18:0/0:0) | ChEBI | | (2R)-2-Hydroxy-3-(stearoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphoric acid | Generator | | LyPC(18:0) | HMDB | | LyPC(18:0/0:0) | HMDB | | LysoPC a C18:0 | HMDB | | Stearoyl alpha-lysolecithin | HMDB | | Stearoyllysophosphatidylcholine | HMDB | | 1-Octadecyl-glycero-3-phosphocholine | HMDB | | 1-Stearoyl-sn-glycero-3-phosphorylcholine | HMDB | | Stearoyl L-alpha-lysolecithin | HMDB | | 1-Stearoyl-2-hydroxy-sn-glycero-3-phosphocholine | HMDB | | Stearoyl alpha-lysolecithin, (+-)-isomer | HMDB | | Stearoyl alpha-lysolecithin, (R)-isomer | HMDB | | 1-Octadecanoyl-glycero-3-phosphocholine | HMDB | | 1-Octadecanoylglycerophosphocholine | HMDB | | 1-Octadecylglycerophosphocholine | HMDB | | 1-Stearoylglycerophosphocholine | HMDB | | 1-O-Stearoyl-2-lyso-sn-glycero-3-phosphocholine | HMDB | | 1-Octadecanoyl-3-glycerophosphorylcholine | HMDB | | 1-Octadecanoyl-sn-glycerol-3-phosphorylcholine | HMDB | | 1-Octadecanoyllysolecithin | HMDB | | 1-Stearoyl-2-lysophosphatidylcholine | HMDB | | 1-Stearoyl-3-glycerylphosphorylcholine | HMDB | | 1-Stearoyl-GPC | HMDB | | 1-Stearoyl-lysophosphatidylcholine | HMDB | | 1-Stearoyl-sn-glycero-3-phosphocholine | HMDB | | 1-Stearoyl-sn-glycerol-3-phosphatidylcholine | HMDB | | 1-Stearoyl-sn-glycerol-3-phosphorylcholine | HMDB | | 1-Stearoylglycero-3-phosphorylcholine | HMDB | | 1-Stearoyllysophosphatidylcholine | HMDB | | GPC(18:0) | HMDB | | GPC(18:0/0:0) | HMDB | | Lysophosphatidylcholine C18:0 | HMDB | | Stearoyl L-α-lysolecithin | HMDB | | Stearoyl lysolecithin | HMDB | | Stearoyl lysophosphatidylcholine | HMDB | | LysoPC(18:0/0:0) | Lipid Annotator, ChEBI |
|
|---|
| Chemical Formula | C26H54NO7P |
|---|
| Average Mass | 523.6832 Da |
|---|
| Monoisotopic Mass | 523.36379 Da |
|---|
| IUPAC Name | (2-{[(2R)-2-hydroxy-3-(octadecanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium |
|---|
| Traditional Name | (2-{[(2R)-2-hydroxy-3-(octadecanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@](O)(COC(=O)CCCCCCCCCCCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C |
|---|
| InChI Identifier | InChI=1S/C26H54NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h25,28H,5-24H2,1-4H3/t25-/m1/s1 |
|---|
| InChI Key | IHNKQIMGVNPMTC-RUZDIDTESA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerophospholipids |
|---|
| Sub Class | Glycerophosphocholines |
|---|
| Direct Parent | 1-acyl-sn-glycero-3-phosphocholines |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1-acyl-sn-glycero-3-phosphocholine
- Phosphocholine
- Fatty acid ester
- Dialkyl phosphate
- Organic phosphoric acid derivative
- Phosphoric acid ester
- Alkyl phosphate
- Fatty acyl
- Tetraalkylammonium salt
- Quaternary ammonium salt
- Secondary alcohol
- Carboxylic acid ester
- Carboxylic acid derivative
- Monocarboxylic acid or derivatives
- Organic oxide
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Alcohol
- Organic oxygen compound
- Organopnictogen compound
- Carbonyl group
- Organic salt
- Amine
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Shim J, Kim MJ, Kim HK, Kim DH, Oh SG, Ko SY, Jang HG, Kim JW: Morphological effect of lipid carriers on permeation of lidocaine hydrochloride through lipid membranes. Int J Pharm. 2010 Mar 30;388(1-2):251-6. doi: 10.1016/j.ijpharm.2009.12.049. Epub 2010 Jan 7. [PubMed:20060459 ]
- Soler-Cantero A, Jove M, Cacabelos D, Boada J, Naudi A, Romero MP, Cassanye A, Serrano JC, Arola L, Valls J, Bellmunt MJ, Prat J, Pamplona R, Portero-Otin M, Motilva MJ: Plant-derived phenolics inhibit the accrual of structurally characterised protein and lipid oxidative modifications. PLoS One. 2012;7(8):e43308. doi: 10.1371/journal.pone.0043308. Epub 2012 Aug 29. [PubMed:22952663 ]
- Jung JH, Jeong SJ, Kim JH, Jung SK, Jung DB, Lee D, Sohn EJ, Yun M, Lee HJ, Lee HJ, Kim SH: Inactivation of HDAC3 and STAT3 is critically involved in 1-stearoyl-sn-glycero-3-phosphocholine-induced apoptosis in chronic myelogenous leukemia K562 cells. Cell Biochem Biophys. 2013;67(3):1379-89. doi: 10.1007/s12013-013-9670-0. [PubMed:23729004 ]
|
|---|